Dr. Telfah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Shawnee Mission Parkway
Suite 210
Westwood, KS 66205Phone+1 913-588-0348Fax+1 913-588-4085
Education & Training
- University of IowaM.S., Clinical Investigation, 2017
- Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 2012 - 2015
- Jordan University of Science and Technology FOMClass of 2010
Certifications & Licensure
- IA State Medical License 2015 - 2022
- KS State Medical License 2018 - 2021
Awards, Honors, & Recognition
- Best Medical Documentation Award UIHC Hospitalist Program, 2017
- Residency Program Medical Jeopardy Winner 2014
- Resident of the Month for Two Consecutive Months 2013
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsClostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation RecipientsRa'ed Jabr, Wissam El Atrouni, Leyla Shune, Mohammad Telfah, Guangyi Gao
Transplantation and Cellular Therapy. 2021-02-01 - 4 citationsMetastatic Plasmacytoid Bladder Cancer Harboring a CDH-1 Mutation and Producing High Levels of CA 19-9. A Case Report and Literature Review.Mohammad Telfah, Rahul Atul Parikh, Da Zhang, Anup Kasi
The American Journal of Case Reports. 2020-07-09 - 4 citationsHydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.Eyad Z. Gharaibeh, Mohammad Telfah, Benjamin C. Powers, Michael Salacz
Journal of Oncology Pharmacy Practice. 2019-10-01
Journal Articles
- Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathyGharaibeh EZ., Telfah M., Powers BC., Salacz ME., J Oncol Pharm Pract, 1/1/2018
- Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New YorkSamhouri, Y., Telfah M., Kouides R., Woodlock T., J Community Hosp Intern Med Perspect, 1/1/2016
Books/Book Chapters
Abstracts/Posters
- Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene SignatureMohammad Telfah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- In-house next generation sequencing (NGS) panel to measure the frequency of recurrent genetic mutations in newly diagnosed AML patients: A single institution experience.Telfah, M., Gharaibeh, E., Balmaceda, N., Abdelhakim, H., Godwin, A., Pessetto, Z., Lin,T., KUCC Research Symposium, Overland Park, KS, 1/1/2018
- A Rare Cause of Anemia: 74-year-old male with high-grade neuroendocrine tumor of the colon.Balmaceda, N., Telfah, M., Al-Kasspooles, M., Dai, H., Neupane, P., Baranda, J., Kansas Chapter of the American Collage of Physician, Lenexa, KS, 1/1/2018
- Join now to see all
Lectures
- The prognosis of NF1 mutations in newly diagnosed AML: A single-center retrospective study.2019 ASCO Annual Meeting - 6/1/2019
- Abiraterone acetate in comparison to enzalutamide in African American patients with metastatic castrate-resistant prostate cancer: A single-center retrospective study.2019 ASCO Annual Meeting - 6/1/2019
- A window of opportunity trial of atorvastatin in p53-mutant and p53 wild type malignancies.2019 ASCO Annual Meeting - 6/1/2019
Other
- Urinary Tract Infection. Visual Dx, Computerized Decision Support ToolSasan Sazgar, Mohamad Jandali, Mohammad Telfah, Nayef El-Daher, Zaw Min
http://www.visualdx.com/visualdx/7/dxDetails.do?moduleId=101&diagnosisId=53386
1/1/2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: